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ABSTRACT
Objective: Prediabetes is a high-risk condition for diabetes development and several other health outcomes later in life, but little is known about 
the factors associated with this condition. On the other hand, by predicting the risk of prediabetes, it is also a golden period for prevent or delay the 
diabetes conversion. The aim here was to assess the prevalence, risk factor that associated, and build a model to assess prediabetes risk.
Methods: A cross-sectional study was conducted in Palembang, Indonesia. Data were collected during January until May 2016. We recruited adult 
age >15 years from 16 districts in Palembang. Anthropometric, demographic, and clinical history data were measured by standard methods. Capillary 
blood glucose was measured by finger prick test, followed by confirmatory oral glucose tolerance tests.
Results: Of a total of 1241 participants, the prevalence of prediabetes was 27.8% (345 participants) and 72.2% (896 participants) and those were 
normal blood glucose. Employment, age, exercise, alcohol consumption, body mass index, systolic pressure, diastolic pressure, waist circumference, 
and hypercholesterol history were screened out as independent factors to build the prediction risk model.
Conclusion: The prediabetes prediction model can be used easily and understood by health-related users to assess prediabetes risk. The intervention 
program, designed based on our prediabetes model to prevent or delay the conversion of prediabetes to diabetes in the population. The discovery of 
pharmacological therapies to prevent further conversion is needed.
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INTRODUCTION
Diabetes mellitus is one of the common chronic diseases occurs 
in all countries. Indonesia is the world’s fourth most populated 
country; it also has the seventh largest number of diabetic patients 
(7.6 million). Diabetes caused at least USD 548 billion dollars (11% 
of the total health spending on adults worldwide) in 2013 [1]. 
Diabetes is a disease that recognized when it is too late to cure. In 
addition, there are some reasons that exacerbate the problem: The 
impact of diabetes on morbidity and mortality is well known [1-3]; 
the diagnosis was usually delayed around 4-7 years after disease 
onset largely due to the absence of symptoms during the early 
years [4], and 10-20% of persons with Type 2 diabetes are found 
to have developed cardiovascular complications by the date of 
diagnosis [5]. Indeed, this is why the promotion of healthy lifestyles 
and an early diagnosis constitutes a key strategic line of approach to 
this health problem [6].
Prediabetes is a high-risk condition for diabetes development and 
several other health outcomes later in life. For example, in 2012, 
86 million Americans had prediabetes, putting them at 5-10% per year 
and 50% lifetime cumulative risk for diabetes. Prediabetes was defined 
as impaired fasting glucose (fasting plasma glucose 100-125 mg/dL) 
impaired glucose tolerance (plasma glucose 140-199 mg/dL 2 hrs after 
75 g oral glucose load, known as oral glucose tolerance testing [OGTT]), 
or the combination of both conditions (which is called combined 
glucose intolerance) [7]. However, many individuals were unware that 
they were suffering from unknown diabetic or prediabetes or metabolic 
abnormalities, live with high plasma glucose levels for many years. Such 
levels may lead to establishment of tissue damage before classical signs 
and symptoms of this condition have become clinically established 
(polyuria, polydipsia, weight loss with or without polyphagia, and 
blurred vision) [8].
Diabetes affects approximately 10% of the world’s adult population 
and is one of the leading risk factors for cardiovascular disease, renal 
failure, and visual impairment [3,9]. On the other hand, their evidence 
that changes in lifestyle can reduce or delay the appearance of diabetes 
in prediabetic individuals [10]. It is important to identify individuals 
with higher probability of presenting some glucose metabolism 
disorder and know the risk factors [6]. The prediction risk model 
is a practical and efficient tool to assess individual’s prediabetes 
development status and screen out the target population at high risk. 
At present, there exist many diabetes risk score models that could 
be used to optimize the estimation of diabetes risk and make related 
intervention plans. However, the risk model for prediabetes is rather 
rare, whereas it is also a golden period to prevent diabetes. This study 
aimed to build a prediabetes risk score model based on population 
data. We anticipated that our prediabetes risk score model could help 
physicians to assess the progress of the conversion of prediabetes to 
diabetes and make related intervention plans to help patients prevent 
or delay the onset of diabetes. The secondary objective of the study was 
to find anthropometric characteristics that might be related to glucose 
intolerance among individuals. We hypothesized that a population 
would show a prevalence of prediabetes states of at least 20%. We also 
hypothesized that demographic and anthropometric characteristics 
that might be related to glucose intolerance among individuals.
METHODS
Study design and sample
We conducted a cross-sectional study in which we analyzed data 
from a population at 16 districts at Palembang city, Indonesia during 
January until May 2016. There are Alang-Alang Lebar, Bukit Kecil, 
Gandus, Ilir Barat I, Ilir Barat II, Ilir Timur I, Ilir Timur II, Kalidoni, 
Kemuning, Kertapati, Plaju, Sako, Seberang Ulu I, Seberang Ulu II, 
Sematang Borang dan Sukarami. The study was approved by the 
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government research committee of South Sumatera (protocol 
number 070/2354/BAN.KBP/2016). We recruited participants 
that had eligibility criteria for participants (inclusion and exclusion 
criteria). The study included 1241 participants that had aged 
>15 years and willing to do the examination a glucose tolerance test 
and physical examination weight, height, blood pressure, and waist 
circumference. And feature data to support on a variable risk of 
developing diabetes mellitus which was a history of hypertension, 
history of hypercholesterolemia, and family history with diabetics. 
All participant did not constitute exclusion criteria; there were 
previous diagnosis of diabetes mellitus or a prediabetic state, use of 
oral hypoglycemic agents or insulin, use of drugs that would interfere 
with glucose and insulin metabolism, such as angiotensin-converting 
enzyme inhibitors, angiotensin receptor blockers and thiazide 
diuretics, use of drugs that would interfere with the serum levels of 
high-density lipoprotein-cholesterol and triglycerides, and use of any 
pharmacological drugs to treat obesity.
Testing procedures
In the first phase, research team comes to home of the participant and 
give a standard questionnaire with information sheet and consent 
form. If participants agree, the next day examination was conducted. 
Data were collected through interviews using questionnaires, physical 
examinations with collection of anthropometric data and blood tests as 
described below.
OGTT measurements
Standard OGTT with a dose of 1.75 g glucose per kilogram of body 
weight (up to a maximum of 75 g) after a 10 hrs overnight fast 
was done. OGTT was performed during standardized conditions. 
Participants were instructed to live as normal as possible in respect 
to diet and physical activity the days before the OGTT. The test 
was postponed to another day in the event of ongoing infection. 
They were also instructed not to exercise and to abstain from food, 
fluids (except water) and tobacco before the test. Prediabetes 
(fasting glucose 100-125 mg/dl equivalent to 5.6-6.9 mmol/L or 2 hrs 
glucose 140-199 mg/dl equivalent to 7.8-11.0 mmol/L) and diabetes 
(fasting glucose ≥126 mg/dl equivalent to ≥7.0 mmol/L or 2 hrs glucose 
≥200  mg/dl  equivalent  to  ≥11.1  mmol/L)  was  defined  by  glucose 
levels obtained during the OGTT according to the American Diabetes 
Association guidelines [11].
Anthropometric measurements
Anthropometric measurements - including height, weight, and waist 
circumferences - measured by the research team following standard 
protocols. Standing height is measured using a stadiometer bar, 
without shoes, with shoulders in a relaxed position and arms hanging 
freely, and recorded to the nearest 0.1 cm. Body weight is measured 
when wearing light clothing with- out shoes on a digital electronic 
weighing scale (TD 150, range 4-150 kg). Body mass index (BMI) 
is then calculated as the weight (kg) divided by height (m2). BMI 
adapted from WHO were categorized as: Underweight (BMI <18.50), 
healthy  weight  (18.50≤  BMI  ≤22.99),  heavlyweight  (23.99≤  BMI 
≤24.99), overweight (25.0≤ BMI ≤29.99), and obese (BMI ≥30). Waist 
circumference is measured while the patients were standing, at the end 
of exhalation, at the midpoint between the lower costal border and the 
top of the iliac crest, using an inelastic tape in a horizontal position. 
Waist circumferences was categorized as: Very low risk (female: 
<27.5 cm; male: <80 cm), low risk (female: 70-89 cm; male: 80-99 cm), 
high risk (female: 90-109 cm; male: 100-120 cm), and very high risk 
(female: >110 cm; male: >120 cm).
Blood pressure measurements
Blood pressure and pulse rate will also be taken to double check those 
written in medical records. They are measured twice in a sitting position 
after the participant has rested for at least 5 minutes. Measurements 
were taken 2 times on the right arm with short intervals between 
readings, and the average of blood pressure readings was calculated 
and used for analysis.
Statistical analysis
Statistical analyses were performed using the SPSS, version 22. The 
statistical significance level was set at p<0.05. Continuous variables 
were expressed as the mean±standard deviation for the variables with 
normal distribution. Categorical variables expressed as percentages. 
Differences between groups relating to categorical variables were 
determined using the Chi-square test and t-tests were used to compare 
means for continuous variables. We estimated the percentage of 
patients who presented each of these risk factors in the subjects with 
prediabetes and in the subjects without glucose metabolism disorders. 
The estimates were expressed in odds ratio and 95% confidence 
intervals. The variables in the logistic regression model were screened 
out to build the risk score model.
RESULTS
A total of 1241 participant identified that prevalence prediabetes 
(27.8%). Table 1 shows the prevalence of prediabetes for various 
demographic characteristics. A greater proportion of prediabetes group 
aged >40 years had significantly (p<0.005) when compared with the 
non-prediabetes group (Table 1). The percentage of prediabetes was 
significantly higher in the age group> 40 years, married or with partner 
and unemployment (p <0.005).
Table 2 shows the change in prevalence of prediabetes was not 
significant for groups had a family history of diabetes and with smoking 
status (p>0.005). The  proportion of prediabetes was significantly 
higher in not routinely exercise group (30.5%) and routinely exercise 
for groups with prediabetes was 19.5%; the difference in proportion 
was statistically significant. The difference in BMI proportion was 
significant among prediabetes and without prediabetes group; the 
highest proportion was grouped with healthy weight and the smaller 
proportion was underweight group. A higher percentage of prediabetes 
group with history hypercholesterolemia (90%) and was significant 
compared among the non prediabetes group. The mean of systolic blood 
pressure (mmHg) of prediabetes group was 129.79±17.70 and mean of 
the non prediabetes group was 122.95±17.18, and the difference was 
significant. The difference mean of diastolic blood pressure and sistolic 
blood pressure among prediabetes and nonprediabetes also significant 
(p<0.005).
Table 3 from multivariate analysis with binary regression logistic, we 
five variable as risk factor, that were employment, exercise, alcohol 
consumption, systolic pressure, and diastolic pressure. Moreover, 
four protective variables that were age, BMI, waist circumference and 
hypercholesterolemia history. The percent correct model to prediction 
prediabetes was 87.7%.
Logit  (Prediabet)=−2.925−0.370  (Age)  +  0.076(employment)  +  0.482 
(exersice) + 1.257 (alcohol consumption) – 0.174 (BMI) + 0.0247 (systolic) 
+  0.034  (diatolic)  –  (waist  circumference)  –  5.149  (hypercholesterol 
history).
DISCUSSION
The increase in the prevalence of diabetes associated with cardiovascular 
disease and the accompanying high morbidity and mortality make 
glucose perturbations a serious public health issue. Hence, early 
intervention in or prevention of prediabetes status should receive 
greater attention. In this study, we built a prediabetes risk score model 
that involves age, employment, exercise, alcohol consumption, BMI, 
diastolic blood pressure, systolic blood pressure, waist circumference, 
and hypercholesterol history of diabetes as risk factors. The risk factors 
used in our risk score model are consistent with the diabetes and 
prediabetes risk factors reported in previous literature [8,12,13].
An interesting thing to consider was a family history of diabetes 
variable that’s not significant to prediabetes group. These results were 
contrasted with findings from a population-based survey of civilian, 
non-institutionalized US and community-based populations in China, 
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which also found that sibling history was a significant risk factor for 
diabetes [14,15]. Family history of diabetes may reflect the influence of 
both genetic and common environmental exposures shared within the 
family, therefore, knowledge of family history may be the first step toward 
determining the contribution of genetic and environmental factors in 
the development of diabetes [16]. In this study, it was possible because 
the group who has a family history of diabetes may have high levels of 
awareness of the risk factors of diabetes. Other variables must consider 
too was smoking, in this study, there was not significant to predict 
prediabetes. The underlying mechanism of cigarette smoking induced 
increased Type 2 diabetes is not entirely clear. Plausibility smoking was 
not directly related to blood glucose levels but might interact with body 
fat. Therefore, Zhang et al. study showed coexistence of current smoking 
and abdominal obesity contributes to the highest diabetes risk [17].
Screening in the prediabetes risk status has the best choice for 
prevention diabetes program, prediabetes has a golden period for 
prevent or delay the diabetes conversion. Recent data have confirmed 
the predisposition of subjects presenting with prediabetes to develop 
Type 2 diabetes. Patients presenting with normal glucose tolerance 
showed an 8% incidence of new-onset diabetes after 5 years, whereas 
33% of individuals with impaired glucose tolerance developed Type 2 
diabetes during the same time period [18]. Developing countries 
such as Indonesia also showed an increased prevalence of diabetes. 
Indonesia is the 4th country with the largest population in the world 
and held the position of the 7th country; most people with diabetes are 
7.6 million people [19]. However, the detection rate of diabetes was still 
low, RISKESDAS Indonesia show in 2013, from 6.9% of diabetics, 30.4% 
had been diagnosed earlier, while 69.6% are not diagnosed previously.
Some evidence has shown that lifestyle modifications, as the 
cornerstone of diabetes prevention, could lead to a 40-70% relative-risk 
reduction [20]. Compared with interventions after the onset of diabetes, 
the related intervention measures started during the prediabetes stage 
are more efficient and sensible because they can prevent or delay the 
conversion from prediabetes to diabetes [12,16].
The main limitation of this study was inherent in its cross-sectional 
design. It was not possible to determine cause and effect relationships, 
but rather, only associations could be reported. Another important 
limitation of this study was the fact that plasma hemoglobin A1c 
(HbA1c) assays were not performed on the research subjects, because 
when this study was planned and conducted, performing plasma 
HbA1c assays as a screening test for non-diabetic individuals was 
not part of the usual recommendations. Unfortunately, it was not 
possible to include HbA1c evaluations in this study consequent to that 
recommendation, because the blood of large samples was no longer 
stored. However, the main strength of this study is the focus on the 
prediabetes state.
Furthermore, we have included a large number of participants from 
a population based. This study provides useful information when 
considering early detection of individuals with high risk of development 
diabetes and cardiovascular diseases. The detection of prediabetes 
in an individual should be accompanied by interventions addressing 
modifiable risk factors. The available evidence is still scarce; further 
studies are needed to check these findings and to confirm possible 
explanations, such as HbA1c and use cohort study with follow up. 
Intensive lifestyle changes and appropriate vitamin D supplementation 
may need to prevent or delay the prediabetes progression [21]. 
Vitamin D can improve insulin resistance and sensitivity and blood 
pressure regulations [22]. Pharmacological therapies also essentially 
Table 1: General characteristics of the population studied among prediabetes and non‑prediabetes
Characteristics Prediabetes (yes) Prediabetes (no) Total
n=1241
p value
n=345 (27.8%) n=896 (72.2%)
Sex
Male 165 (28.4) 415 (71.6) 580 0.679
Female 180 (27.2) 481 (72.8) 661
Age
<40 years 119 (19.9) 479 (80.1) 598 0.000*
>40 years 226 (35.1) 417 (64.9) 643
Marital status
Without partner 62 (20.9) 235 (79.1) 297 0.003*
Married or with partner 283 (30.0) 661 (70.0) 944
Education
Primary 42 (28.4) 106 (71.6) 148 0.726
Middle school 179 (28.6) 446 (71.4) 625
High school 124 (26.5) 344 (73.5) 468
Employment 
Unemployment 31 (32.3) 65 (67.7) 96 0.001*
Government 45 (29.0) 110 (71.0) 155
Employees 13 (22.8) 44 (77.2) 57
Teacher 29 (25.4) 85 (74.6) 114
Freelance 25 (30.1) 58 (69.9) 83
Trader 10 (9.7) 93 (90.3) 103
Student 86 (31.4) 188 (68.6) 274
Housewife 10 (29.5) 25 (70.5) 359
Others 6 3
Race
Palembang 201 (25.8) 579 (74.2) 780 0.182
Jawa 54 (34.2) 104 (65.8) 158
Batak 20 (40.8) 29 (59.2) 49
Melayu 28 (25.0) 84 (75.0) 112
Ambon 1 (33.3) 2 (66.7) 3
Betawi 2 (40.0) 3 (60.0) 5
Sunda 6 (27.3) 16 (72.7) 22
Padang 15 (24.2) 47 (75.8) 62
Cina 18 (36.0) 32 (64.0) 50
*Indicates the significance at the level<0.05
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needed; one of that is pioglitazone. Pioglitazone is known to reduce risk 
of atherosclerosis in prediabetic and diabetic subjects. Pioglitazone is 
insulin sensitizer which improves and maintain long-term glycemic 
control along with its favorable cardiovascular effect especially 
macrovascular complications [23].
CONCLUSION
In the sample studied, the prevalence of prediabetes was 27.8%. We 
found nine variables were screened out as independent factors to 
build the prediction risk model. Five variables as risk factors that 
were employed, exercise, alcohol consumption, systolic pressure, and 
diastolic pressure. Moreover, four protective variables that were age, 
BMI, waist circumference, and hypercholesterol history. The variables 
have been the modifiable risk factors independently related to the 
presence of prediabetes; just age has not modifiable risk factors. The 
discovery of pharmacological therapies to prevent further conversion 
of prediabetes to diabetes is needed.
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